| Tag | Content |
|---|
EnhancerAtlas ID | HS023-22484 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr6:155463550-155465570 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr6:155464604-155464625 | TATTAGTTTCACTTTTCTCCC | + | 6.11 | | IRF1 | MA0050.2 | chr6:155464563-155464584 | ATTTAGTTTCACTTTTCTCCC | + | 6.32 | | IRF2 | MA0051.1 | chr6:155464603-155464621 | CTATTAGTTTCACTTTTC | - | 6.46 | | IRF2 | MA0051.1 | chr6:155464562-155464580 | CATTTAGTTTCACTTTTC | - | 6.56 | | NFE2L1 | MA0089.2 | chr6:155465027-155465042 | AAAGCTGAGTCATGC | - | 6.43 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_37927 | chr6:155463115-155465478 | HSMMtube | | SE_46292 | chr6:155462974-155465708 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH06I155141 | chr6 | 155462780 | 155465514 |
|
Enhancer Sequence | CATTTCCTCT AGATGCCACG ATTTAAACCA TGGCTGTTGG AATTCCAGTG TTAGGGAAGC 60
TGGGAAGTGA ACGTGAACCC ATTGGAAAGA ATTTGGACGT GTGTGCAGCT GGAGCTGCTC 120
TGCCCCTTTG CCCTGGTCCT CGGGCCCCGG GTCATGGCTT GTAGCATGTG CAACAGTAGC 180
ATCAGATGGG CCTTACTCGA TGAGAAGACT TGGTTTATAG TTTAACTGCT GCATCAGTGG 240
CTGGAAAAAG ATACTGGCCA GGCCTGCAAG AAGCAGCTCT GGCTGTAAAC CTCTTGCTAC 300
TTTCCCTTGT TTGTAATACT TGAGTTCTGT CAGCCTGTTA GTTTGGATGA GTTTTATTTG 360
CGGGGAGGAG CAAATGCGCA GTTTCTTGAG ATCATAAAGT ACCATGGAGG GAGAAAGTAC 420
TGCTTCCGAA GTCCAAGCTT GGAGCAGGCA TCTTTCTCTC TTGGCTTCTA TGTGCTGTTA 480
TCGGTTCTAT TGTATAAACT TGTTTGTTCA TATCAAGACT TATTTTTAAA GGAAGTAATG 540
AAATTGGAAA GACTGAAATA GTTTTCAAAA CGTCTGAACT TTTATGAATG AGGATGCAAA 600
CACAGTAGTA GGATAAAGTA CCGTGAAGTG GGCCCCAGGC ATTTGTTTAC AGTGAAGGCA 660
GGCTGGTGTT TCTTTCCTGT CAATGTGAAA GGCACTTGCG AAGCACCCAG ATGGTGGTCA 720
TGTCATTGTT ATTCGTATGC TGGAGGTTGC CACATGAGAA GTGGTCAAAA AAGTTTATTG 780
GATACAGATT TGAGGGGATA GTTAACCTAT ACAAGAGGAC ACATTTGTGA GCATTTTAGA 840
AGCATTAGTT TGCTTAAAAA TTGTGTCTAA TAATTATAAT GCAATTTCTA ATTAATGAAG 900
CAAACTCTTA ATAACTTCTA CCTGCAATAC TTTATTTGCT TATGAGGGGA AGAGTAAGTA 960
CTTAAAAGCA TATGTTGCAG TATTTTTAGA GTAACGTTTG AAAATTCAGG CACATTTAGT 1020
TTCACTTTTC TCCCTTAGTC TAAGTAATGT TTTCTATTAG TTTCACTTTT CTCCCTTAGC 1080
CTAAGTAATG TTTTCTATTA CTGTGAGATA AAAGGAAATA CTAAAAATTA AGTTATTTTA 1140
CATGGCATTT GGAGAACAAA CCGGGTACTT TCTCATAAAT GGCAAAGTCC CCTAGGTATG 1200
TTCAGTTTCT TGTTCCCATT GATGGTCAAC GGAGTGAGTG AGTGTGGGAT TTTCTGTGGC 1260
CTCTTACATT GAGATTCCCT AAATAATGTG GTGTTGTGCT TAAGGATGAG GGCTTTGGGG 1320
CCAGAGGGCC TGAGTTCACA TCCCTGCTGC TCCACAGTGC AGCGGTGGGA CCCCTGCAAG 1380
GAATTCGATC TCTCAGTTTT CTCATTTTTA GTGTGAAAGG AAAATAAAAC CTGGGGACCC 1440
CAATTCCTGA TGCCAGAAGG AAAAAAAAAA CAAGCCGAAA GCTGAGTCAT GCAAGAAGCT 1500
GCCTTTCCTT TTCTTTCTAA GCAGGAGCTA CAGATAAAAG GTTAAATATC CCCACAGGTA 1560
GCTAGCTACT CTGTGTTCAC CTTATCTTAT GTAAAGTGCT GGATGATTAC GTGATTGACA 1620
GTTCCCCTGC CTGCTCCTTT TCCCTTGCAG CAGGTGGATT ACCATGCTCT CCCTCGTTCC 1680
TCTCCAGCCC ACTTTTAATT TTTAAACACT GAAGCCCTCA ACATCGTCTT TGGAGAAAAG 1740
CACAGACCAC AGACTATTTC TGTGATTCTG TGTTCTCTTC CTCCGGGCAT GTCCACAACT 1800
TTGGCAAAAT AAACTTCTCA ATGGATCGAG ACCAGTCCTA GATACTTTTT GGGTCACAGT 1860
AGAATGGGCT AAATAACCCT GCCCACCTTA GGGCCTCTAT GGGGATTAAA TAAGCCAGTG 1920
CATGTGGAGT ACTTAGAAGA GTTAAGCAAC AACTTATTAT TTGGTATTGT TATTACTGAT 1980
ATTACATTTA CAAAGACATC TCATTTTCAT TCAAGTTCAT 2020
|
